ERAL1 and breast cancer: Repressive complexes may be recruited by negative regulators such as FOXC1 or other repressors, including the transcription factor ELF5, shown to repress ESR1 and a set of ERα-associated genes with promotion of basal-like breast cancer characteristics [203].